Nucletron Technologies

Nucletron is a global leader in the field of brachytherapy, a specialized form of internal radiation therapy used to treat various types of cancer. The company's portfolio includes the industry-standard microSelectron afterloading systems and the Oncentra treatment planning software, which enable clinicians to deliver precise radiation doses directly to the tumor site while minimizing exposure to surrounding healthy tissue. Founded in 1975 and headquartered in the Netherlands, Nucletron was acquired by Elekta in 2011 for approximately €365 million. Today, Nucletron's technologies form the core of Elekta's brachytherapy division, supporting oncology centers worldwide in providing high-quality, targeted cancer care.